From October 2004, Rothwell served as vice-president for research of the university.[29][30] In 2010 she was overseeing a research group of about 20 scientists, with significant external funding and was announced to succeed Alan Gilbert as president and vice-chancellor of the University of Manchester on 1 July 2010. She is a trustee of Cancer Research UK, the Campaign for Medical Progress, a council member of BBSRC, chair of the Research Defence Society and the Wellcome Trust's Public Engagement Strategy Committee and a non-executive director of AstraZeneca. In 1998 she delivered the Royal Institution Christmas Lecture on The Secrets of Life, televised by the BBC.[31]
President and vice-chancellor
In January 2010, Rothwell was appointed deputy president and deputy vice-chancellor. Until Alan Gilbert retired she was acting president due to his sick leave. On 21 June 2010, she was appointed president and vice-chancellor of the University of Manchester. She assumed her post on 1 July 2010, succeeding Gilbert, who had retired after nearly six years. She became the first woman to lead the University of Manchester or either of its two predecessor institutions.[32] Commenting on her appointment, she said: "I am honoured and delighted to be invited to lead the University at this exciting time. I am determined to maintain the strategic focus that we have developed over the past six years and to work closely with colleagues to identify new priorities and opportunities for the University in the very challenging external environment that we will face over the next few years."[citation needed]
The chairman of the appointment panel and chairman-elect of the university's board of governors, Anil Ruia, said: "Dame Nancy will bring her own distinctive strengths, perspective and style to the role of President and Vice-Chancellor which will enable the University to build upon the remarkable progress that we have made under Professor Alan Gilbert's leadership."[citation needed] In 2009, Rothwell served as the first president of the Society of Biology.[citation needed]
In May 2020, Rothwell was appointed as the chair of the Russell Group, starting September 2020.[19] The group represents 24 of the leading universities in the UK.
In 2023 it was announced that Rothwell would stand down as President and Vice-chancellor of the University in 2024.[33]
In April 2020, Rothwell wrote to University of Manchester staff warning that the loss of revenue caused by the COVID-19 pandemic would result in pay cuts and possible job losses.[34][35] In September 2020 she warned that students who failed to follow social distancing rules could be excluded from the university campus.[36]
In the autumn 2020 semester the university's handling of the pandemic and the second national lockdown led to criticism and protests.[37][38] In September 2020, university officials said they had taken precautions including staggered arrivals, social distancing and a reduced lecture timetable, though university staff alleged they were being pressured into conducting face-to-face teaching.[37] In October 2020 the Fallowfield area, home to the university's Fallowfield Campus, saw more COVID-19 cases than any other part of the UK.[37] Rothwell launched an investigation after fences were erected around campus residences in November 2020 and apologised for the university's "very poor communication" with students.[39][40] Days later students began a rent strike and occupied a campus building and demanded Rothwell meet with them to discuss a proposed rent discount.[41][42] Later in November Rothwell acknowledged the university had made "mistakes" in its approach to the pandemic and said that, while many students supported the measures, others felt "let down".[37] The inquiry issued a report in December 2020, which identified failures of project management on the university's part and a failure to engage with students; Rothwell accepted the inquiry's findings and pledged to implement its recommendations.[43]
Also in November 2020, anti-racist campaigners called on Rothwell to resign following an incident in which a black student was detained and allegedly racially profiled by university security guards.[38] A Universities and Colleges Union official said Rothwell should "offer a full apology" to the student "and stop trying to police the university's student population".[37] In an interview on Newsnight, Rothwell said that she had contacted the student to apologise.[44][45] At the time of the interview she had not, in fact, contacted the student, and she later apologised for claiming she had done so.[46][47]
In February 2021, the University of Manchester Students' Union (UMSU) called a vote of no confidence in Rothwell, the first time in the university's history such a motion has been triggered.[48][49][50] The students obtained the requisite 400 signatures to launch the referendum in hours.[49] The campaign also called for the vice-chancellor to be elected by staff and students.[49] In March 2021 the vote of no confidence was passed with the support of 89 percent of voters. The vote, however, was non-binding and a spokesperson for the university said it had "full confidence" in Rothwell.[51][52]
Rothwell retired from her position as Vice Chancellor in July 2024 and was succeeded by Duncan Ivison.[12][33]
Nancy Rothwell has made major discoveries in the areas of energy balance, host defence responses, and neurodegeneration, several of which are now being translated into clinical benefit. Early work emphasised the importance of thermogenesis in the regulation of energy balance and the aetiology of obesity, and the role of b2 adrenoreceptor activation in muscle hypertrophy. More recently she has carried out pioneering studies of the role of cytokines and other components of the immune system within the central nervous system. She demonstrated the key role of specific cytokines and the hormone leptin in the integration and regulation by the brain of host defence responses to infection and injury. This led to important discoveries concerning the role of cytokines in neurodegeneration. She was the first to show that the cytokine IL-1 mediates ischaemicbrain damage, challenging the view that immune or inflammatory processes are unimportant in the brain. She patented the use of IL-1 inhibitors to prevent acute neurodegeneration and is leading the first clinical trial of such an inhibitor in stroke. Her demonstration that caspases are involved directly in ischaemic brain damage in vivo stimulated the development of caspase inhibitors for possible clinical application. Nancy Rothwell has also worked energetically to advance physiology and neuroscience, to further public awareness of science, and to encourage women to pursue careers in science.
^Selvarajah, J.; Scott, M.; Stivaros, S.; Hulme, S.; Georgiou, R.; Rothwell, N.; Tyrrell, P.; Jackson, A. (2008). "Potential surrogate markers of cerebral microvascular angiopathy in asymptomatic subjects at risk of stroke". European Radiology. 19 (4): 1011–1018. doi:10.1007/s00330-008-1202-8. PMID18987865. S2CID417275.
^Selvarajah, J. R.; Smith, C. J.; Hulme, S.; Georgiou, R.; Sherrington, C.; Staniland, J.; Illingworth, K. J.; Jury, F.; Payton, A.; Ollier, W. E.; Vail, A.; Rothwell, N. J.; Hopkins, S. J.; Tyrrell, P. J. (2011). "Does inflammation predispose to recurrent vascular events after recent transient ischaemic attack and minor stroke? The North West of England transient ischaemic attack and minor stroke (NORTHSTAR) study". International Journal of Stroke. 6 (3): 187–194. doi:10.1111/j.1747-4949.2010.00561.x. PMID21557802. S2CID25940748.
^Roe, S. Y.; Cooper, A. L.; Morris, I. D.; Rothwell, N. J. (1997). "Involvement of prostaglandins in cachexia induced by T-cell leukemia in the rat". Metabolism: Clinical and Experimental. 46 (4): 359–365. doi:10.1016/S0026-0495(97)90047-0. PMID9109835.